BRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Vaxxas Pty Ltd, the biotechnology company pioneering the high-density microarray patch (HD-MAP) for needle-free vaccine delivery, today announced that it has secured ~$90 million in its latest financing round. The financing is one of the largest financings for a private biotech company in Australia this year and […]